Compare ImmunityBio Inc. Common Stock (IBRX) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Stitch Fix Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while Stitch Fix Inc trades at $2.74 (market cap $365.41M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 28.3× Stitch Fix Inc's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Stitch Fix Inc for 31 Days on average.
| IBRX | SFIX | |
|---|---|---|
Market Cap | $10.33B | $365.41M |
Volume | 11,745,198 | 3,317,935 |
Sector | Health | Consumer Cyclical |
52-Week High | $11.55 | $5.64 |
52-Week Low | $1.98 | $2.16 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $10.79B | $261.21M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Stitch Fix (SFIX) trades at $2.73, up 2.25% today, showing recent earnings beats but facing bearish technical signals. The company reported improved financials with narrowing losses (-$28.74M net income in 2025 vs -$129M in 2024) and stable $1.27B revenue, though negative cash flow and weak FY27 guidance weigh on sentiment. Analyst consensus is mixed with 24% Buy ratings but a $3.40 price target suggesting 25% upside.
Outlook remains challenging with ongoing profitability concerns and legal investigations creating headwinds. The stock offers speculative appeal given low P/S ratio and AI-driven growth initiatives, but execution risks and competitive pressures require careful monitoring. Near-term performance hinges on reversing active client declines and achieving sustainable EBITDA positivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
